In The News

Read the latest news about scientific breakthroughs, clinical findings and special events benefiting neurofibromatosis research.

NF Center Researchers Use Novel Treatment for Brain Tumors

Dr. Kevin Cross, neurosurgery resident and National Institute of Health R25 grant awardee, recently published on the use of MRI-guided...

FuNFest and Forward Strides 2022

Originally published in the St. Louis Children’s Hospital Foundation Newsletter. This year marked the 7th year for Forward Strides 4NF...

NF Center Investigators Review Current NF Clinical Trials

Simge Acar, a Children’s Tumor Foundation Young Investigator Awardee, Dr. Angela Hirbe, and Dr. Amy Armstrong recently published a cogent...

Dr. Brossier Welcomes Two New Laboratory Members

Nicole Brossier, MD, PhD, Assistant Professor in Pediatrics, has begun to expand her independent research laboratory. Following her postdoctoral fellowship with...

NF Center Researchers Report a Breakthrough in Pediatric Brain Tumor Modeling

One of the major barriers to discovering and testing new drugs for low-grade gliomas in children is the paucity of...

Adeoye, Guilak, Gutmann, Kipnis elected to National Academy of Medicine

Election is one of the highest honors for contributions to health, medicine Adapted from WUSM News Release; originally written by...

NF Center Researcher Reports Seizure Control in a Child with NF1

MEK inhibitors are one of the emerging treatments for brain tumors in children with NF1. These drugs turn off the...

The Gutmann Laboratory Welcomes Two New Post-Baccalaureate Trainees

This summer, we welcomed Ms. Anna Gabrielsen and Ms. Dahlia Qi to our research family. Anna joins us following the...

Gutmann Awarded New Grant To Study The Immunology of Brain Tumors

David H. Gutmann, MD, PhD, the Donald O. Schnuck Family Professor and Director of the Neurofibromatosis (NF) Center at Washington...

Gilbert Family Foundation Launches NF1 Brain Tumor Initiative

The Gilbert Family Foundation has recently funded several research laboratories as part of its newly launched Brain Tumor Initiative. “We...